GL1X · GenesisL1 explorer

Research workbench

AlphaFold monomer V2.0 prediction for dual-specificity RNA methyltransferase rlmn (A7ZGB0)

Analyse AlphaFold monomer V2.0 prediction for dual-specificity RNA methyltransferase… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

Accession
A7ZGB0
Type
protein
Length
381 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0x9073C46348542FfE4327c3F363F9B51B22058e75
Molecule
Dual-specificity RNA methyltransferase rlmn
UniProt
A7ZGB0
Pockets
2 · best druggability 0.79

Structure

1 distinct chain · 32% helix, 21% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ADual-specificity RNA methyltransferase rlmnprotein38132% helix, 21% strandA7ZGB0

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14980.790.8659empty
2730.310.7418empty

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.